New Key Statistics Module, Z-Score and F-Score
NAS:ORMP Key Ratios
| Market Cap $ M | 93.19 |
| Enterprise Value $ M | -14.39 |
| P/E(ttm) | 16.43 |
| PE Ratio without NRI | 16.43 |
| Forward PE Ratio | -- |
| Price/Book | 0.57 |
| Price/Sales | 70.62 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 36.39 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | 0.14 |
| Beneish M-Score | 1.34 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.72 |
| EV-to-EBITDA | -4.43 |
| PEG | -- |
| Shares Outstanding M | 40.52 |
| Net Margin (%) | 412.31 |
| Operating Margin % | -1,176.79 |
| Pre-tax Margin (%) | 379.70 |
| Quick Ratio | 3.06 |
| Current Ratio | 3.06 |
| ROA % (ttm) | 2.97 |
| ROE % (ttm) | 3.60 |
| ROIC % (ttm) | -30.64 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.71 |
ORMP Number of Guru Trades
ORMP Volume of Guru Trades
Gurus Latest Trades with NAS:ORMP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ORMP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Oramed Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ORMP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers